Status:
COMPLETED
Neuralgic Amyotrophy: Central Reorganization and Rehabilitation After Peripheral Dysfunction
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Princess Beatrix Muscle Foundation
Conditions:
Neuralgic Amyotrophy
Neuralgic Amyotrophy, Hereditary
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the effect of a specific, multidisciplinary and personalized rehabilitation program compared to usual care, on motor control and functional disability in patients with neuralgic a...
Detailed Description
Neuralgic amyotrophy (NA) is a common (incidence 1:1000) peripheral nervous system disorder caused by acute autoimmune inflammation of the brachial plexus, the nerve bundle going to the shoulder and a...
Eligibility Criteria
Inclusion
- (Suspected) diagnosis of neuralgic amyotrophy
- In subacute or chronic phase of neuralgic amyotrophy (\>2 months after attack onset)
- Right-handed
- Neuralgic amyotrophy predominantly present in right upper extremity
- Presence of scapular dyskinesia
Exclusion
- Patients in the acute phase of NA (characterized by severe pain and inflammation of the brachial plexus)
- (Prior) NA attacks of the lumbosacral plexus or the left upper extremity
- Sever comorbidity
- Any (bio)mechanical constraints of the shoulder girdle
- Any other central nervous system, neurological, or neuromuscular disorder
Key Trial Info
Start Date :
April 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03441347
Start Date
April 4 2018
End Date
February 22 2021
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud university medical center
Nijmegen, Netherlands